Strain Information | |
---|---|
Image | |
BRC No. | RBRC04022 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | C57BL/6-Sept8<tm1> |
Former Common name | Sept8-flox |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Hauke B. Werner, Max Planck Institute of Experimental Medicine. |
Strain description | Genetic background:C57BL/6Normal, unless crissed with Cre mice.Exon 2 is flanked by loxP sites.Two phage P1 loxP, one yeast FRT (flipase recombination target) sites. |
Colony maintenance | Immuno status of animal:Normal |
References |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info |
Ordering Information | |
---|---|
供与核酸 | phage P1 loxP, yeast FRT (flipase recombination target) sites, mouse Sept8 genomic DNA |
Research application | |
提供条件 | 条件を付加する。 A recipient shall acquire a prior written consent from the Depositor using the Approval form, and file an MTA with the DEPOSITOR. For-profit institutions or use for commercial research purposes shall acquire a prior written consent from the DEPOSITOR, file an MTA, and a licensing agreement. A recipient shall acquire a prior written consent from the Depositor prior to filing an application for a patent, or intellectual property or other rights based on the results of research using the BIOLOGICAL RESOURCE. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. This MTA covers the BIOLOGICAL RESOURCE and all progeny, including genetically modified progeny yielded after breeding with mice expressing Cre-recombinase. |
Depositor | Hauke B. Werner(Max Planck Institute) |
Strain Status | 凍結胚 凍結精子 |
Strain Availability | 凍結胚より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 凍結胚を1ヶ月以内に提供可能 |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |